🔎 Trials Near Me

Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › Distaarikii Koloombiyaa › Washington

Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Washington, DC keessatti

Qorannoo 9 Kansera Urothelial (Cell Transitional) f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Sibley Memorial Hospital Pharmacy Department, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07277413

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Namoota walitti qabaa jiraSadarkaa 3
  • MedStar Washington Hospital Center, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07218380

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • Research Site, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07815665

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Medstar Washington Hospital Center, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06774131

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Namoota walitti qabaa jiraSadarkaa 2
  • National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT06161532

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Namoota walitti qabaa jiraSadarkaa 2
  • Medstar Washington Hospital Center, Washington D.C.
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT04879329

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Silver Spring · Miili 7 fagaatti
  • Massive Bio SYNERGY-AI site, Bethesda · Miili 7 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti

Qorannoo biroo Washington keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.